Johnson & Johnson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Johnson & Johnson (NYSE:JNJ) will release earnings results for the first quarter, before the opening bell on Tuesday, April 15.

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 per share in the year-ago period. Johnson & Johnson projects to report quarterly revenue at $21.57 billion, compared to $21.38 billion a year earlier, according to data from Benzinga Pro.

Protagonist Therapeutics, on April 10, announced new data for a pill that treats moderate-to-severe plaque psoriasis. The Phase 3 study was conducted in adolescents and adults simultaneously. The ICONIC program, with icotrokinra (JNJ-2113) data from a subgroup analysis, came about through a partnership with Johnson & Johnson.

Johnson & Johnson shares gained 1.7% to close at $154.36 on Monday.

Benzinga ...

https://www.benzinga.com/25/04/44806571/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts